Coverage guide
Zepbound Medicare Coverage Questions
Zepbound questions can involve more than one use. FDA approved Zepbound for chronic weight management in adults with obesity or overweight with at least one weight-related condition, and later approved it for moderate to severe obstructive sleep apnea in adults with obesity.
CMS beneficiary guidance says GLP-1 drugs prescribed for a use coverable under the basic Medicare Part D benefit, including Zepbound for moderate to severe obstructive sleep apnea in adults with obesity, are not furnished through the Medicare GLP-1 Bridge. That means the right path can depend on the submitted diagnosis and the plan's rules.
Ask the prescriber and plan what diagnosis will appear on the authorization request, whether Zepbound is on formulary for that use, whether an exception or appeal is needed, and whether the chosen pharmacy is in network.
What to check next
Confirm the exact medication, diagnosis, formulary tier, prior authorization requirement, step therapy status, and pharmacy network before relying on a listing.
Useful documents
Plan formularies, Evidence of Coverage documents, pharmacy directories, and written prior-authorization criteria are more reliable than verbal summaries alone.